Comparative efficacy of long-acting β2-agonists as monotherapy for chronic obstructive pulmonary disease: a network meta-analysis

Autor: Donohue JF, Betts KA, Du EX, Altman P, Goyal P, Keininger DL, Gruenberger JB, Signorovitch JE

Publikováno v: International Journal of COPD, Vol Volume 12, Pp 367-381 (2017)

James F Donohue,1 Keith A Betts,2 Ella Xiaoyan Du,2 Pablo Altman,3 Pankaj Goyal,4 Dorothy L Keininger,4 Jean-Bernard Gruenberger,4 James E Signorovitch5 1Department of Pulmonary Diseases and Critical Care Medicine, The University of North Carolina, C

Externí odkaz: https://doaj.org/article/83b091428ec14721811556ae6700bb15

Costs of Adverse Events in Patients with Advanced or Metastatic Renal Cell Carcinoma with First-Line Treatment.

Autor: Chen Y; Analysis Group, Inc., Los Angeles, CA, USA., Du EX; Analysis Group, Inc., Los Angeles, CA, USA. Ella.Du@analysisgroup.com., Sundar M; Analysis Group, Inc., Los Angeles, CA, USA., Betts KA; Analysis Group, Inc., Los Angeles, CA, USA., Yin X; Bristol Myers Squibb, Princeton, NJ, USA., Eiffert S; Bristol Myers Squibb, Princeton, NJ, USA., Beauchamp K; Bristol Myers Squibb, Princeton, NJ, USA., Delgado A; Bristol Myers Squibb, Princeton, NJ, USA., Rosenblatt L; Bristol Myers Squibb, Princeton, NJ, USA.

Publikováno v: PharmacoEconomics - open [Pharmacoecon Open] 2024 Nov 06. Date of Electronic Publication: 2024 Nov 06.

Long-Term Temporal Trends of Real-World Healthcare Costs Associated with Nivolumab Plus Ipilimumab and Pembrolizumab Plus Axitinib as First-Line Treatment for Advanced or Metastatic Renal Cell Carcinoma.

Autor: Du EX; Analysis Group, Inc., Los Angeles, CA, USA. ella.du@analysisgroup.com., Betts KA; Analysis Group, Inc., Los Angeles, CA, USA., Wang T; Analysis Group, Inc., Los Angeles, CA, USA., Kitchen SA; Analysis Group, Inc., Los Angeles, CA, USA., He X; Analysis Group, Inc., Los Angeles, CA, USA., Yin X; Bristol Myers Squibb, Princeton, NJ, USA., Guttenplan SB; Bristol Myers Squibb, Princeton, NJ, USA., Beauchamp K; Bristol Myers Squibb, Princeton, NJ, USA., Delgado A; Bristol Myers Squibb, Princeton, NJ, USA., Rosenblatt L; Bristol Myers Squibb, Princeton, NJ, USA.

Publikováno v: Oncology and therapy [Oncol Ther] 2024 Dec; Vol. 12 (4), pp. 735-751. Date of Electronic Publication: 2024 Aug 10.

Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data.

Autor: Moser JC; HonorHealth Research Institute, 10510 North 92nd Street, Suite 100, Scottsdale, AZ, 85258, USA. jmoser@honorhealth.com., Bhatia S; Division of Hematology and Oncology, Fred Hutchinson Cancer Center, Seattle, WA, USA., Amin A; Medical Oncology and Immunotherapy, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Pavlick AC; Medical Oncology, Weill Cornell Medicine, New York, NY, USA., Betts KA; Analysis Group, Los Angeles, CA, USA., Du EX; Analysis Group, Los Angeles, CA, USA., Poretta T; Bristol Myers Squibb, Princeton, NJ, USA., Shelley K; Bristol Myers Squibb, Princeton, NJ, USA., Srinivasan S; Bristol Myers Squibb, Princeton, NJ, USA., Sakkal LA; Bristol Myers Squibb, Princeton, NJ, USA., Palaia J; Bristol Myers Squibb, Princeton, NJ, USA., Lobo M; Bristol Myers Squibb, Princeton, NJ, USA., Pe Benito M; Bristol Myers Squibb, Princeton, NJ, USA., Linton JA; Bristol Myers Squibb, Princeton, NJ, USA., Chen Y; Analysis Group, Los Angeles, CA, USA., Xu C; Analysis Group, Los Angeles, CA, USA., Yin L; Analysis Group, Los Angeles, CA, USA., Sundar M; Analysis Group, Los Angeles, CA, USA., Weber J; NYU Langone Health Perlmutter Cancer Center, New York, NY, USA.

Publikováno v: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 May 07; Vol. 73 (7), pp. 116. Date of Electronic Publication: 2024 May 07.

Real-world safety of first-line immuno-oncology combination therapies for advanced non-small-cell lung cancer.

Autor: Betts KA; Health Economics & Outcome Research, Analysis Group Inc., Los Angeles, CA 90071, USA., Gao S; Health Economics & Outcome Research, Analysis Group Inc., Los Angeles, CA 90071, USA., Ray S; Health Economics & Outcome Research, Bristol Myers Squibb, Lawrenceville, NJ 08648, USA., Schoenfeld AJ; Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, NY 10065, USA.

Publikováno v: Future oncology (London, England) [Future Oncol] 2024 Apr; Vol. 20 (13), pp. 851-862. Date of Electronic Publication: 2024 Jan 19.